Suppr超能文献

一种用于治疗乳腺癌的新型嵌合蛋白的理论设计。

Theoretical design of a new chimeric protein for the treatment of breast cancer.

作者信息

Soleimani Meysam, Mahnam Karim, Mirmohammad-Sadeghi Hamid, Sadeghi-Aliabadi Hojjat, Jahanian-Najafabadi Ali

机构信息

Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

Biology Department, Faculty of Sciences, Shahrekord University, Shahrekord, I.R. Iran.

出版信息

Res Pharm Sci. 2016 May-Jun;11(3):187-99.

Abstract

p28 and NRC peptides are two anticancer peptides with various mechanisms have shown to be effective against breast cancer. Therefore, it seems that construction of a chimeric protein containing the two peptides might cause synergistic cytotoxic effects. However, since the two peptides bear opposite charges, production of a chimeric protein in which the two moieties do not intervene each other is difficult. In this study, our goal was to find a suitable peptide linker for the new chimeric protein in a manner that none of the peptides intervene the other's function. We selected some linkers with different characteristics and lengths and created a small library of the chimeric proteins harboring these linkers. Homology modeling and molecular dynamic simulation revealed that (PA)5P and (EAAAK)3 linkers can separate the p28 and NRC peptides effectively. Thus, the chimeric protein linked with (PA)5P or (EAAAK)3 linkers might show synergistic and stronger anticancer effects than the separate peptide moieties because they could exert their cytotoxic effects freely which is not influenced by the other part.

摘要

p28和NRC肽是两种具有多种作用机制的抗癌肽,已证明对乳腺癌有效。因此,构建一种包含这两种肽的嵌合蛋白可能会产生协同细胞毒性作用。然而,由于这两种肽带相反电荷,很难生产出一种两个部分互不干扰的嵌合蛋白。在本研究中,我们的目标是以一种肽不干扰另一种肽功能的方式,为新的嵌合蛋白找到合适的肽接头。我们选择了一些具有不同特性和长度的接头,并创建了一个包含这些接头的嵌合蛋白小文库。同源建模和分子动力学模拟表明,(PA)5P和(EAAAK)3接头可以有效分离p28和NRC肽。因此,与(PA)5P或(EAAAK)3接头连接的嵌合蛋白可能比单独的肽部分表现出协同且更强的抗癌作用,因为它们可以自由发挥其细胞毒性作用,而不受另一部分的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa1c/4962299/d2396babb9a7/RPS-11-187-g002.jpg

相似文献

2
design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells.
Res Pharm Sci. 2020 May 11;15(2):200-208. doi: 10.4103/1735-5362.283820. eCollection 2020 Apr.
3
A Bi-Functional Targeted P28-NRC Chimeric Protein with Enhanced Cytotoxic Effects on Breast Cancer Cell Lines.
Iran J Pharm Res. 2019 Spring;18(2):735-744. doi: 10.22037/ijpr.2019.2392.
4
Expression and purification of toxic anti-breast cancer p28-NRC chimeric protein.
Adv Biomed Res. 2016 Apr 19;5:70. doi: 10.4103/2277-9175.180639. eCollection 2016.
5
The Enhanced Cytotoxic Effects of the p28-Apoptin Chimeric Protein As A Novel Anti-Cancer Agent on Breast Cancer Cell Lines.
Drug Res (Stuttg). 2019 Feb;69(3):144-150. doi: 10.1055/a-0654-4952. Epub 2018 Jul 30.
8
Design and construction of chimeric linker library with controllable flexibilities for precision protein engineering.
Methods Enzymol. 2021;647:23-49. doi: 10.1016/bs.mie.2020.12.004. Epub 2020 Dec 26.
9
Design of the linkers which effectively separate domains of a bifunctional fusion protein.
Protein Eng. 2001 Aug;14(8):529-32. doi: 10.1093/protein/14.8.529.
10

引用本文的文献

1
Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment.
Res Pharm Sci. 2025 Mar 31;20(2):165-187. doi: 10.4103/RPS.RPS_75_24. eCollection 2025 Apr.
3
Investigation of therapeutic potential of the Il24-p20 fusion protein against breast cancer: an in-silico approach.
In Silico Pharmacol. 2024 Sep 18;12(2):84. doi: 10.1007/s40203-024-00252-x. eCollection 2024.
4
From antimicrobial to anticancer: unraveling the potential of pleurocidin and pleurocidin-derived peptides in the treatment of cancers.
Front Pharmacol. 2024 Jan 26;15:1340029. doi: 10.3389/fphar.2024.1340029. eCollection 2024.
5
The potential of monoclonal antibodies for colorectal cancer therapy.
Med Oncol. 2023 Aug 21;40(9):273. doi: 10.1007/s12032-023-02151-1.
7
Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin.
Front Oncol. 2021 Dec 16;11:781800. doi: 10.3389/fonc.2021.781800. eCollection 2021.
9
design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells.
Res Pharm Sci. 2020 May 11;15(2):200-208. doi: 10.4103/1735-5362.283820. eCollection 2020 Apr.
10
Targeted Diphtheria Toxin-Based Therapy: A Review Article.
Front Microbiol. 2019 Oct 18;10:2340. doi: 10.3389/fmicb.2019.02340. eCollection 2019.

本文引用的文献

2
Design and characterization of structured protein linkers with differing flexibilities.
Protein Eng Des Sel. 2014 Oct;27(10):325-30. doi: 10.1093/protein/gzu043.
3
Cancer statistics, 2014.
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
4
Breast cancer statistics, 2013.
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1.
5
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.
Bioinformatics. 2013 Apr 1;29(7):845-54. doi: 10.1093/bioinformatics/btt055. Epub 2013 Feb 13.
6
Cancer treatment using peptides: current therapies and future prospects.
J Amino Acids. 2012;2012:967347. doi: 10.1155/2012/967347. Epub 2012 Dec 20.
7
The future of peptide-based drugs.
Chem Biol Drug Des. 2013 Jan;81(1):136-47. doi: 10.1111/cbdd.12055.
8
Fusion protein linkers: property, design and functionality.
Adv Drug Deliv Rev. 2013 Oct;65(10):1357-69. doi: 10.1016/j.addr.2012.09.039. Epub 2012 Sep 29.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验